Clinical trials: Chronic Phase CML, BCR-ABL1 Positive
- Condition Chronic Phase CML, BCR-ABL1 Positive
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Leukemia
Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of troxacitabine in treating patients who have blast…
- Trial name
- NCT00012259
- Testing
- troxacitabine
- Where
- 20 sites in United States, Canada
- Volunteers
- 31 people
- Sponsor
- Shire